Age-Related Thrombophilia: Multifactorial Prothrombotic Mechanisms
The increased thrombotic risk with aging results from a constellation of acquired hemostatic changes—including elevated procoagulant factors, impaired fibrinolysis, endothelial dysfunction, and chronic low-grade inflammation—rather than from inherited thrombophilia, which remains constant throughout life.
Key Epidemiologic Context
The risk of venous thromboembolism (VTE) increases dramatically with age: approximately 1 in 10,000 persons per year before age 40, escalating to 1 in 100 persons per year after age 75 1. This represents a 100-fold increase in absolute risk. Importantly, this age-related increase occurs independently of inherited thrombophilic conditions like Factor V Leiden or prothrombin G20210A mutation, which confer fixed genetic risk throughout life 1.
Primary Mechanisms of Age-Related Hypercoagulability
Elevated Procoagulant Factors
Aging is associated with progressive increases in multiple coagulation proteins 2:
- Fibrinogen levels rise with age (also an acute phase reactant)
- Factor VII, VIII, and IX concentrations increase
- Von Willebrand factor (VWF) levels elevate
- Thrombin generation becomes enhanced
These changes create a baseline prothrombotic state that is measurable in otherwise healthy elderly individuals 2, 3.
Altered Fibrin Clot Structure and Function
Age-related oxidative stress modifies fibrinogen through post-translational modifications, particularly carbonylation 4. This results in:
- Formation of more compact, tightly-woven fibrin networks
- Impaired fibrinolytic susceptibility—clots become more resistant to breakdown
- Enhanced clot stability that persists longer in circulation
This represents a novel mechanism contributing to both arterial atherothrombosis and venous thrombosis 4.
Impaired Fibrinolysis
The fibrinolytic system becomes progressively dysfunctional 2, 3:
- Plasminogen activator inhibitor-1 (PAI-1) levels increase
- Overall fibrinolytic activity decreases
- This compounds the effect of more resistant fibrin clots
Endothelial Cell Senescence
Accumulation of senescent endothelial cells fundamentally alters the vessel wall's antithrombotic properties 5, 6:
- Loss of normal anticoagulant functions (prostacyclin production, thrombomodulin expression)
- Development of senescence-associated secretory phenotype (SASP), which promotes a prothrombotic microenvironment
- Impaired endothelial repair mechanisms and reduced proliferation/migration capacity
- Decreased re-endothelialization after vascular injury
Platelet Hyperreactivity
Age-related platelet changes include 3:
- Increased responsiveness to aggregating stimuli
- Elevated beta-thromboglobulin levels
- Enhanced thromboxane A2 production
- Altered platelet membrane lipid composition (increased cholesterol/phospholipid ratio)
- Decreased prostacyclin and thromboxane A2 receptor numbers
Chronic Low-Grade Inflammation ("Inflammaging")
A progressive inflammatory state develops with aging 7, characterized by:
- Elevated inflammatory markers
- Increased acute phase reactants (fibrinogen, Factor VIII)
- This inflammatory milieu directly activates coagulation pathways
The finding that healthy centenarians exhibit similar hypercoagulable patterns suggests this state is compatible with longevity, though it increases thrombotic risk 7.
Evidence of Coagulation Activation
Markers of ongoing coagulation activation increase with age 3:
- Fibrinopeptide A (indicates thrombin activity on fibrinogen)
- Prothrombin fragment F1+2 (indicates Factor Xa activity)
These demonstrate that the elderly exist in a state of chronic, subclinical coagulation activation.
Clinical Implications
Inherited Thrombophilia Considerations
Inherited thrombophilias do NOT increase with age—they are present from birth 8. However:
- First VTE episodes in Factor V Leiden carriers typically occur after age 50 9
- This reflects the interaction between fixed genetic risk and acquired age-related prothrombotic changes
- Testing for inherited thrombophilia should not be limited to young patients 9
Risk Assessment
Age itself is recognized as a strong independent risk factor across multiple guidelines 10, 11:
- Age ≥70 years scores 1 point in the Padua Prediction Score
- Age >60 years scores 1 point in the IMPROVE VTE risk model
- Age >85 years significantly increases bleeding risk with anticoagulation 10
Common Pitfall
Do not attribute age-related thrombotic risk to inherited thrombophilia. The mechanisms are distinct: inherited conditions provide a constant genetic predisposition, while aging creates an acquired, progressive prothrombotic state through the mechanisms outlined above.
Arterial vs. Venous Thrombosis
While traditionally viewed as distinct entities, both arterial and venous thrombosis share common age-related risk factors 1:
- Aging
- Immobility
- Obesity
- Chronic inflammation
Arterial thrombosis is primarily driven by atherosclerosis, but the age-related hemostatic changes described above contribute to both pathways 12.